INTENSIVE CARE UNIT
Quickly identify fluid imbalances related to medical conditions, trauma or organ failure
Body composition obtained via bioelectrical impedance is important for understanding a patient’s fluid status and physiological makeup to be used for guiding treatments aimed at improving patient status, decreasing the length of hospital stay, and reducing the risk of mortality. InBody devices are non-invasive and convenient, making them ideal for implementing into the ICU for patient assessments. The InBody Test produces comprehensive results that physicians can use to monitor fluid levels and health to improve patient outcomes. InBody provides a cost-effective strategy in a highly complex personalized care setting.
In less than 60 seconds, the InBody Test provides easy-to-understand, accurate and objective measurements to evaluate the patient’s health upon ICU admittance and for monitoring progress throughout the hospital stay. Physicians can use the InBody to:
-
Identify fluid imbalances related to medical conditions, trauma or organ failure
-
Track fluid overload and management
-
Monitor body composition variables for muscle loss and cachexia
-
Assess risk of malnutrition
Gain an in-depth analysis on body composition to improve recovery and prognosis
Patients who are bedridden or in critical care experience significant muscle loss, leading to decreased physical function and poor long-term outcomes after discharge.
InBody allows for frequent and reliable testing to monitor changes in body composition, including muscle and fat balance, to guide patient care programs towards preserving lean mass and mobility.
Significant losses of fat-free mass can occur within two days of bed rest in the ICU. In addition to prolonged bed rest, inflammatory processes and treatments, such as sedation, further contribute to muscle and bone catabolism. This impacts functional ability, which can delay full recovery and have long-term effects on cognitive health and survival. Maintaining lean mass has been linked to improved recovery and prognosis for patients in the ICU, thus proper nutrition and early mobilization are necessary strategies to prevent muscle depletion in the ICU setting.
InBody’s Segmental Lean Analysis (SLA) allows critical care professionals to monitor fat-free mass and ECW/TBW values in each segment of the body, providing an in-depth analysis on body composition, elucidating where musculature may be deficient, decreasing, or requiring improvement. In addition to segmental distribution, monitoring both lean mass and body water values helps guide treatments and provides a better understanding of unintentional weight loss. This serves as a more direct measure for effectively distinguishing weight fluctuations resulting from changes in fluid or muscle-fat balance.
Physical therapists and clinical nutritionists can also use the Muscle-Fat Analysis (MFA) and SLA to identify patient needs and provide appropriate treatments or nutritional therapies to maintain lean mass and prevent frailty or ICU-acquired weakness. With non-invasive tracking of nutritional status and body composition, critical care professionals will be able to more effectively treat patients with earlier interventions, resulting in improved health status at ICU discharge and better patient outcomes overall.
